Purpose Frailty, a phenotype reported among 9.9% of individuals 65 years old and older
(9.6% of women; 5.2% of men), has not been assessed among adult childhood cancer …

PURPOSE To estimate the prevalence of frailty among childhood cancer survivors and to
determine the direct and indirect effects of treatment exposures, lifestyle factors, and severe …

Young adult childhood cancer survivors are at an increased risk of frailty, a physiologic
phenotype typically found among older adults. This phenotype is associated with new‐onset …

The improvement in survival of childhood cancer observed across the past 50 years has
resulted in a growing acknowledgment that simply extending the lifespan of survivors is not …

Background: An objective measure is needed to identify frail older adults with cancer who
are at increased risk for poor health outcomes. The primary objective of this study was to …

There are over 15 million survivors of cancer in the United States whose rates of frailty, an
aging phenotype, range from just under 10% to over 80%. Frailty impacts not only disease …

There are almost 14-million cancer survivors in the United States and the population is
growing. Almost two-thirds of these survivors are age 65 or older. Given this, it is imperative …

Background Frailty is a state of vulnerability to poor resolution of homeostasis following a
stressor event, such as chemotherapy or cancer surgery. Better knowledge of the …

Importance Understanding changes in frailty in relation to cancer diagnosis can inform
optimal selection of cancer treatments and survivorship care. Objective To investigate …

Frailty, an age-related condition of increased vulnerability to acute endogenous or
exogenous stressors, is a key barrier to successful treatment of cancer in older people. In …